Vector Science and Therapeutics Corp. has seen some recent fluctuations in its stock performance amid company developments.
This week, Vector Science and Therapeutics Corp. (PAIN.V) experienced a slight decline in its stock price, closing at C$1.91, down 0.53% for the day and 1.06% over the week. Despite these recent dips, the stock has shown remarkable growth year-to-date, up 285.57%. Let's take a closer look at the factors influencing its performance.
Advertisement
Vector Science and Therapeutics Corp.
PAIN.V
PAIN.V
Vector Science and Therapeutics Corp.
WealthAwesomeMarket cap
$293.96M
52W high
$2.65
52W low
$0.35
1W change
-1.06%
Beta
4.67
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PAIN's historical volatility
30-Day Vol
102.0%
Annualized
90-Day Vol
98.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.60
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.80 | C$1.27 – C$2.56 |
| 60 trading days | C$1.70 | C$1.03 – C$2.79 |
| 90 trading days | C$1.60 | C$0.87 – C$2.94 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should keep an eye on Vector Science and Therapeutics Corp.'s ongoing developments and stock performance, especially given its significant year-to-date gains despite recent price fluctuations.
285.57% Year-to-Date Growth
Despite recent price declines, Vector Science and Therapeutics Corp. has seen a remarkable increase in its stock price since the beginning of the year, highlighting strong market interest.
Bull case
The impressive year-to-date performance suggests strong investor interest and potential value in Vector Science and Therapeutics Corp. Continued developments in their operations could further boost stock performance.
Bear case
The recent decline in stock price, along with a high beta of 4.67, indicates significant volatility, which may worry risk-averse investors. Additionally, the company has not yet achieved profitability, as shown by a profit margin of 0.0%.
Recent Price Action
Advertisement
Vector Science and Therapeutics Corp. closed at C$1.91, reflecting a 0.53% decline for the day and a 1.06% decrease over the past week. This performance comes against a backdrop of remarkable year-to-date growth of 285.57%, indicating strong investor interest despite the recent fluctuations.
Company News
On September 25, 2026, Vector Science and Therapeutics Corp. issued options, which may signal potential future developments within the company. While specific details about the options were not disclosed, such actions often indicate a focus on incentivizing employees or raising capital for growth initiatives. Investors should stay tuned for further announcements that could impact the company's direction.
Technical Picture
Looking at the technical indicators, Vector Science and Therapeutics Corp. is currently trading above its 50-day moving average of C$1.81 by 5.6% and its 200-day moving average of C$1.72 by 10.8%. The stock has a 52-week range of C$0.35 to C$2.65, placing it at 68% of its range. With a beta of 4.67, the stock shows significant volatility compared to the market, which may attract both risk-tolerant and cautious investors alike. Notably, the latest trading volume of 459,130 shares is significantly higher than the 20-day average volume of 98,051 shares, indicating increased investor interest.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
